MedTrace Logo

CHANGE Cancer Alberta: A Primary Care Program for Cancer Prevention and Screening

NCT02893163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2023-06-23

No results posted yet for this study

Summary

The primary purpose of this trial will be to test the effectiveness of CHANGE intervention to increase physical activity, improve diets, reduce obesity and reverse Metabolic Syndrome among adult patients identified as at risk for cancer due to diet and physical activity behaviours when implemented in typical primary care settings within the Alberta context.

Conditions

  • Metabolic Syndrome
  • Risk Factors

Interventions

BEHAVIORAL

CHANGE Intervention

Canadian Health Advanced by Nutrition and Graded Exercise Protocol

OTHER

Usual Care

Usual Care by Family Doctor

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Alberta Innovates Health Solutions

    collaborator OTHER

  • Alberta Pulse Growers

    collaborator OTHER

  • Alberta Health services

    collaborator OTHER

  • Metabolic Syndrome Canada

    collaborator UNKNOWN

  • University of Alberta

    lead OTHER

Principal Investigators

  • Doug Klein, MD, MSc · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2022-06-30
Completion
2023-01-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02893163 on ClinicalTrials.gov